KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer

BACKGROUND: In spite of great progress in the surgical and clinical management, until now no significant improvement in overall survival of High-Grade Serous Ovarian Cancer (HGSOC) patients has been achieved. Important aspects for disease control remain unresolved, including unclear pathogenesis, hi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Exp Clin Cancer Res
Asıl Yazarlar: De Donato, Marta, Babini, Gabriele, Mozzetti, Simona, Buttarelli, Marianna, Ciucci, Alessandra, Arduini, Gloria, De Rosa, Maria Cristina, Scambia, Giovanni, Gallo, Daniela
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7702713/
https://ncbi.nlm.nih.gov/pubmed/33250051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-020-01775-9
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller